FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2128589110> ?p ?o ?g. }

• W2128589110 abstract "Abstract Background Sapphyrin analogues and related porphyrin-like species have attracted attention as anticancer agents due to their selective localization in various cancers, including hematologic malignancies, relative to surrounding tissues. Sapphyrins are electron affinic compounds that generate high yields of singlet oxygen formation. Although initially explored in the context of photodynamic therapy, sapphyrins have intrinsic anticancer activity that is independent of their photosensitizing properties. However, the mechanisms for their anticancer activity have not been fully elucidated. Results We have prepared a series of hydrophilic sapphyrins and evaluated their effect on proliferation, uptake, and cell death in adherent human lung (A549) and prostate (PC3) cancer cell lines and in an A549 xenograft tumor model. PCI-2050, the sapphyrin derivative with the highest in vitro growth inhibitory activity, significantly lowered 5-bromo-2'-deoxyuridine incorporation in S-phase A549 cells by 60% within eight hours and increased levels of reactive oxygen species within four hours. The growth inhibition pattern of PCI-2050 in the National Cancer Institute 60 cell line screen correlated most closely using the COMPARE algorithm with known transcriptional or translational inhibitors. Gene expression analyses conducted on A549 plateau phase cultures treated with PCI-2050 uncovered wide-spread decreases in mRNA levels, which especially affected short-lived transcripts. Intriguingly, PCI-2050 increased the levels of transcripts involved in RNA processing and trafficking, transcriptional regulation, and chromatin remodeling. We propose that these changes reflect the activation of cellular processes aimed at countering the observed wide-spread reductions in transcript levels. In our A549 xenograft model, the two lead compounds, PCI-2050 and PCI-2022, showed similar tumor distributions despite differences in plasma and kidney level profiles. This provides a possible explanation for the better tolerance of PCI-2022 relative to PCI-2050. Conclusion Hydrophilic sapphyrins were found to display promise as novel agents that localize to tumors, generate oxidative stress, and inhibit gene expression." @default.
• W2128589110 created "2016-06-24" @default.
• W2128589110 creator A5000215293 @default.
• W2128589110 creator A5009736410 @default.
• W2128589110 creator A5012828947 @default.
• W2128589110 creator A5018006951 @default.
• W2128589110 creator A5018307235 @default.
• W2128589110 creator A5032812187 @default.
• W2128589110 creator A5038703165 @default.
• W2128589110 creator A5041610835 @default.
• W2128589110 creator A5044534950 @default.
• W2128589110 creator A5044627146 @default.
• W2128589110 creator A5057813480 @default.
• W2128589110 creator A5058282645 @default.
• W2128589110 creator A5061517379 @default.
• W2128589110 creator A5072825980 @default.
• W2128589110 creator A5073699171 @default.
• W2128589110 creator A5076423139 @default.
• W2128589110 creator A5091913369 @default.
• W2128589110 date "2007-01-19" @default.
• W2128589110 modified "2023-10-15" @default.
• W2128589110 title "Synthesis and biologic properties of hydrophilic sapphyrins, a new class of tumor-selective inhibitors of gene expression" @default.
• W2128589110 cites W1562335567 @default.
• W2128589110 cites W1611726375 @default.
• W2128589110 cites W1967782318 @default.
• W2128589110 cites W1980548655 @default.
• W2128589110 cites W1995077860 @default.
• W2128589110 cites W1996168369 @default.
• W2128589110 cites W2002203989 @default.
• W2128589110 cites W2009661199 @default.
• W2128589110 cites W2019311731 @default.
• W2128589110 cites W2022334982 @default.
• W2128589110 cites W2025478017 @default.
• W2128589110 cites W2028048410 @default.
• W2128589110 cites W2043989098 @default.
• W2128589110 cites W2049331434 @default.
• W2128589110 cites W2052399139 @default.
• W2128589110 cites W2059525455 @default.
• W2128589110 cites W2060451998 @default.
• W2128589110 cites W2070232655 @default.
• W2128589110 cites W2076051181 @default.
• W2128589110 cites W2081389687 @default.
• W2128589110 cites W2089547687 @default.
• W2128589110 cites W2092943708 @default.
• W2128589110 cites W2101339876 @default.
• W2128589110 cites W2114852050 @default.
• W2128589110 cites W2114918609 @default.
• W2128589110 cites W2119981922 @default.
• W2128589110 cites W2125320515 @default.
• W2128589110 cites W2138349894 @default.
• W2128589110 cites W2141468589 @default.
• W2128589110 cites W2147126535 @default.
• W2128589110 cites W2166866388 @default.
• W2128589110 cites W2170354584 @default.
• W2128589110 doi "https://doi.org/10.1186/1476-4598-6-9" @default.
• W2128589110 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1784109" @default.
• W2128589110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17233922" @default.
• W2128589110 hasPublicationYear "2007" @default.
• W2128589110 type Work @default.
• W2128589110 sameAs 2128589110 @default.
• W2128589110 citedByCount "30" @default.
• W2128589110 countsByYear W21285891102012 @default.
• W2128589110 countsByYear W21285891102013 @default.
• W2128589110 countsByYear W21285891102014 @default.
• W2128589110 countsByYear W21285891102016 @default.
• W2128589110 countsByYear W21285891102018 @default.
• W2128589110 countsByYear W21285891102019 @default.
• W2128589110 countsByYear W21285891102020 @default.
• W2128589110 crossrefType "journal-article" @default.
• W2128589110 hasAuthorship W2128589110A5000215293 @default.
• W2128589110 hasAuthorship W2128589110A5009736410 @default.
• W2128589110 hasAuthorship W2128589110A5012828947 @default.
• W2128589110 hasAuthorship W2128589110A5018006951 @default.
• W2128589110 hasAuthorship W2128589110A5018307235 @default.
• W2128589110 hasAuthorship W2128589110A5032812187 @default.
• W2128589110 hasAuthorship W2128589110A5038703165 @default.
• W2128589110 hasAuthorship W2128589110A5041610835 @default.
• W2128589110 hasAuthorship W2128589110A5044534950 @default.
• W2128589110 hasAuthorship W2128589110A5044627146 @default.
• W2128589110 hasAuthorship W2128589110A5057813480 @default.
• W2128589110 hasAuthorship W2128589110A5058282645 @default.
• W2128589110 hasAuthorship W2128589110A5061517379 @default.
• W2128589110 hasAuthorship W2128589110A5072825980 @default.
• W2128589110 hasAuthorship W2128589110A5073699171 @default.
• W2128589110 hasAuthorship W2128589110A5076423139 @default.
• W2128589110 hasAuthorship W2128589110A5091913369 @default.
• W2128589110 hasBestOaLocation W21285891101 @default.
• W2128589110 hasConcept C104317684 @default.
• W2128589110 hasConcept C150194340 @default.
• W2128589110 hasConcept C151730666 @default.
• W2128589110 hasConcept C190283241 @default.
• W2128589110 hasConcept C2779343474 @default.
• W2128589110 hasConcept C502942594 @default.
• W2128589110 hasConcept C54355233 @default.
• W2128589110 hasConcept C55493867 @default.
• W2128589110 hasConcept C62112901 @default.
• W2128589110 hasConcept C81729549 @default.
• W2128589110 hasConcept C81885089 @default.
• W2128589110 hasConcept C83640560 @default.
• W2128589110 hasConcept C86803240 @default.

• next